Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Models of Investigation
-
1. Antifungal innate immunity in C. elegans
- Dr. Jonathan Ewbank
-
2. The anti-microbial defense of Drosophila: a paradigm for innate immunity
- Prof. Jules Hoffmann
-
3. Phagocytosis in the fruit fly, Drosophila melanogaster
- Dr. Lynda Stuart
-
4. Innate immune sensing and response
- Prof. Bruce Beutler
-
5. Macrophages and systems biology
- Prof. David Hume
- Cell Types and Recruitment
-
6. Leukocyte recruitment in vivo
- Prof. Paul Kubes
-
8. Eosinophils
- Prof. Tim Williams
-
9. Dendritic cells: linking innate to different forms of adaptive immunity
- Prof. Ralph Steinman
-
11. Innate-like lymphocytes 1
- Prof. Adrian Hayday
-
12. Innate-like lymphocytes 2
- Prof. Adrian Hayday
- Recognition and Signaling
-
13. Colony stimulating factor-1 regulation of macrophages in development and disease
- Prof. E. Richard Stanley
-
14. Fc receptors: linking innate and acquired immunity
- Prof. Ken G C Smith
-
15. Phagocytosis
- Prof. Joel Swanson
-
16. Clearance of apoptotic cells and the control of inflammation
- Prof. Sir John Savill
-
17. Signaling by innate immune receptors
- Prof. Michael Karin
-
18. Nuclear receptors at the crossroads of inflammation and atherosclerosis
- Prof. Christopher Glass
- Modulation of Effector Responses
-
19. Humoral innate immunity and the acute phase response 1
- Prof. Alberto Mantovani
-
20. Humoral innate immunity and the acute phase response 2
- Prof. Alberto Mantovani
-
21. Cytokines regulating the innate response
- Prof. Anne O’Garra
-
22. Arginase and nitric oxide
- Dr. Peter Murray
-
23. Novel lipid mediators in resolution of inflammation
- Prof. Charles Serhan
-
25. Cationic peptides in innate immunity
- Dr. Dawn Bowdish
-
26. Iron metabolism and innate immunity
- Prof. Tomas Ganz
- Pathogen-Host Interactions
-
27. Innate recognition of viruses
- Prof. Caetano Reis e Sousa
-
28. Type I interferons in innate immunity to viral infections
- Prof. Christine Biron
-
29. HIV-1 and immunopathogenesis: innate immunity
- Prof. Luis Montaner
-
30. Understanding and combating tuberculosis
- Prof. David Russell
-
32. Innate immunity and malaria
- Prof. Douglas Golenbock
- Health and Disease
-
33. Innate immunity in children
- Prof. David Speert
-
34. From bench to bedside: evolution of anti-TNFalpha therapy in rheumatoid arthritis
- Prof. Sir Ravinder Maini
-
35. NOD-like receptors in innate immunity and inflammatory disease
- Prof. Gabriel Nunez
-
36. Paneth cells in innate immunity and inflammatory bowel disease
- Prof. Satish Keshav
-
37. Innate immunity in the brain in health and disease
- Prof. V. Hugh Perry
-
38. The fate of monocytes in atherosclerosis
- Prof. Gwendolyn Randolph
-
39. Macrophages, a cellular toolbox used by tumors to promote progression and metastasis
- Prof. Jeffrey Pollard
- Archived Lectures *These may not cover the latest advances in the field
-
40. Monocyte/macrophages in innate immunity
- Prof. Emeritus Siamon Gordon
-
41. Innate immunity in C. elegans
- Dr. Jonathan Ewbank
-
43. NLR genes: infection, inflammation and vaccines
- Prof. Jenny Ting
-
44. Manipulation of innate immune response: lessons from shigella
- Prof. Philippe Sansonetti
-
45. Innate immunity of the lung and adaptation to air breathing at birth
- Prof. Jeffrey Whitsett
Printable Handouts
Navigable Slide Index
- Introduction
- C. elegans - structure
- C. elegans - inner structure
- Why C. elegans? physical properties
- Life cycle of C. elegans
- Why C. elegans? genetic aspects
- Micro-injection of C. elegans
- Transgenic C. elegans
- Why C. elegans? advantages as genetic model
- Growing method of C. elegans in the lab
- C. elegans in the natural environment
- The dauer stage
- A dauer pheromone
- Pheromones
- Attraction of males by hermaphrodites
- C. elegans is attracted by bacteria
- C. elegans prefers S. marcescens
- Worms are repelled by S. marcescens
- Worms are not repelled by SM267
- SM267 does not make serrawettin W2
- Implications of the detection mechanism
- C. elegans eats bacteria
- The grinder
- E. coli is broken down in the pharynx
- S. marcescens destrys the grinder
- Infection by S. marcescens
- Response to P. luminescens & Db11
- Host response to infection is specific
- Response specificity - live vs. dead bacteria
- Response specificity - virulence
- Response specificity - virulence and viability (1)
- Response specificity - virulence and viability (2)
- Response specificity - bacteria strain
- Response to infection - a common signature
- EASE with the common response genes
- Infection by P. luminescens - necrotic reporter
- Regulation of necrosis
- Suppression of necrosis
- D. coniospora spores
- Infection of C. elegans by D. coniospora
- nlp and cnc genes are highly up-regulated
- Phylogenetic analysis of nlp and cnc genes
- nlp clusters in three Caenorhabditis species
- nlp cluster in C. elegans
- Over-expression of nlp and resistance
- Epidermal expression of AMP genes
- Induction of nlp-29 after Drechmeria infection
- Induction of pnlp-29::GFP
- Induction of nlp-29
- No induction of nlp-29
- D. coniospora penetrates the cuticle
- Physical injury of C. elegans
- Physical injury triggers wound repair
- Physical injury induces pnlp-29::GFP
- Abnormal epithelial cell development
- Osmotic shock induces pnlp-29::GFP
- AMP gene expression in Drosophila
- Rel homology domain proteins
- TIR domain proteins
- A TIR domain adaptor protein in C. elegans
- p38 MAPK pathway involved in defence
- dapk-1 mutants have a wounded epidermis
- AMP genes are upregulated in dapk-1 mutants
- DAPK is a negative regulator of AMP expression
- A suppressor of the epidermal defects
- Two roles for DAPK
- Open questions
- The nipi mutants (1)
- An example of a nipi mutant
- The nipi mutants (2)
- nipi-1 = PKCdelta
- PKC-delta activation
- Induction by PMA
- G-protein/PKC upstream of the p38 pathway
- nipi-3 affects transcriptional response to infection
- Two signals in response to infection
- Sodium-neurotransmitter symporter family (1)
- Sodium-neurotransmitter symporter family (2)
- Sodium-neurotransmitter symporter family (3)
- Interaction with a STAT like transcription factor
- Physical interaction - SNF-12 and STA-2
- sta-2 is required for nlp-29 induction
- AMP gene regulation in C. elegans
- Conclusions
- Thanks to our collaborators
- The lab members
Topics Covered
- Anatomy of C. elegans
- C. elegans as an experimental animal
- Pheromone signalling and pathogen detection
- Specific and general transcriptional responses to bacterial infection
- Necrosis
- Fungal infection and injury induce antimicrobial peptide genes
- Signal transduction pathways that control antimicrobial peptide gene expression
Talk Citation
Ewbank, J. (2011, November 3). Innate immunity in C. elegans [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/NDGV9579.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Jonathan Ewbank has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.